Iovance Biotherapeutics IncNASDAQ:IOVA
- LAST PRICE7.4200
- TODAY'S CHANGE (%)-0.3700 (-4.7497%)
- Bid / Lots7.5500/ 20
- Ask / Lots7.6500/ 24
- Open / Previous Close7.1200 / 7.7900
- Day Range
- 52 Week Range
- Volume8,105,190
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IOVA |
|---|---|---|
| 09:32 ET | 128961 | 7.29 |
| 09:34 ET | 48356 | 7.31 |
| 09:36 ET | 68202 | 7.31 |
| 09:38 ET | 28138 | 7.34 |
| 09:39 ET | 85957 | 7.41 |
| 09:41 ET | 49272 | 7.255 |
| 09:43 ET | 48037 | 7.295 |
| 09:45 ET | 25585 | 7.38 |
| 09:48 ET | 50720 | 7.3799 |
| 09:50 ET | 16305 | 7.49 |
| 09:52 ET | 65868 | 7.56 |
| 09:54 ET | 112029 | 7.63 |
| 09:56 ET | 65497 | 7.63 |
| 09:57 ET | 31015 | 7.64 |
| 09:59 ET | 35779 | 7.56 |
| 10:01 ET | 12548 | 7.665 |
| 10:03 ET | 14414 | 7.655 |
| 10:06 ET | 32266 | 7.5725 |
| 10:08 ET | 125021 | 7.61 |
| 10:10 ET | 28963 | 7.56 |
| 10:12 ET | 46778 | 7.54 |
| 10:14 ET | 52596 | 7.56 |
| 10:15 ET | 43489 | 7.54 |
| 10:17 ET | 31045 | 7.49 |
| 10:19 ET | 15406 | 7.505 |
| 10:21 ET | 12264 | 7.47 |
| 10:24 ET | 82118 | 7.54 |
| 10:26 ET | 19434 | 7.53 |
| 10:28 ET | 19670 | 7.535 |
| 10:30 ET | 25394 | 7.48 |
| 10:32 ET | 18343 | 7.4768 |
| 10:33 ET | 8114 | 7.475 |
| 10:35 ET | 18592 | 7.53 |
| 10:37 ET | 40322 | 7.49 |
| 10:39 ET | 15749 | 7.48 |
| 10:42 ET | 25312 | 7.5 |
| 10:44 ET | 37768 | 7.54 |
| 10:46 ET | 20397 | 7.575 |
| 10:48 ET | 16493 | 7.59 |
| 10:50 ET | 24620 | 7.62 |
| 10:51 ET | 85295 | 7.5399 |
| 10:53 ET | 16142 | 7.56 |
| 10:55 ET | 12531 | 7.595 |
| 10:57 ET | 14254 | 7.54 |
| 11:00 ET | 15806 | 7.505 |
| 11:02 ET | 8365 | 7.485 |
| 11:04 ET | 18261 | 7.465 |
| 11:06 ET | 20058 | 7.435 |
| 11:08 ET | 12082 | 7.48 |
| 11:09 ET | 9749 | 7.505 |
| 11:11 ET | 30095 | 7.54 |
| 11:13 ET | 10528 | 7.565 |
| 11:15 ET | 5407 | 7.55 |
| 11:18 ET | 5079 | 7.55 |
| 11:20 ET | 7170 | 7.59 |
| 11:22 ET | 13228 | 7.58 |
| 11:24 ET | 12332 | 7.56 |
| 11:26 ET | 5564 | 7.61 |
| 11:27 ET | 22574 | 7.67 |
| 11:29 ET | 26175 | 7.605 |
| 11:31 ET | 7471 | 7.635 |
| 11:33 ET | 13559 | 7.63 |
| 11:36 ET | 16808 | 7.6501 |
| 11:38 ET | 4802 | 7.66 |
| 11:40 ET | 9013 | 7.71 |
| 11:42 ET | 7607 | 7.72 |
| 11:44 ET | 6316 | 7.71 |
| 11:45 ET | 8912 | 7.7 |
| 11:47 ET | 42697 | 7.73 |
| 11:49 ET | 48571 | 7.725 |
| 11:51 ET | 35556 | 7.655 |
| 11:54 ET | 6915 | 7.67 |
| 11:56 ET | 5622 | 7.69 |
| 11:58 ET | 8636 | 7.68 |
| 12:00 ET | 2888 | 7.69 |
| 12:02 ET | 6400 | 7.735 |
| 12:03 ET | 5420 | 7.72 |
| 12:05 ET | 22246 | 7.745 |
| 12:07 ET | 22504 | 7.76 |
| 12:09 ET | 20933 | 7.755 |
| 12:12 ET | 9432 | 7.73 |
| 12:14 ET | 18859 | 7.71 |
| 12:16 ET | 4501 | 7.735 |
| 12:18 ET | 14762 | 7.745 |
| 12:20 ET | 10032 | 7.79 |
| 12:21 ET | 22096 | 7.75 |
| 12:23 ET | 11496 | 7.775 |
| 12:25 ET | 50297 | 7.785 |
| 12:27 ET | 42599 | 7.815 |
| 12:30 ET | 23291 | 7.83 |
| 12:32 ET | 74107 | 7.845 |
| 12:34 ET | 34405 | 7.825 |
| 12:36 ET | 10388 | 7.8184 |
| 12:38 ET | 21331 | 7.76 |
| 12:39 ET | 8350 | 7.75 |
| 12:41 ET | 19085 | 7.685 |
| 12:43 ET | 11516 | 7.745 |
| 12:45 ET | 2685 | 7.71 |
| 12:48 ET | 6050 | 7.68 |
| 12:50 ET | 9319 | 7.65 |
| 12:52 ET | 10720 | 7.635 |
| 12:54 ET | 4675 | 7.64 |
| 12:56 ET | 8207 | 7.66 |
| 12:57 ET | 8042 | 7.645 |
| 12:59 ET | 10582 | 7.67 |
| 01:01 ET | 10689 | 7.675 |
| 01:03 ET | 7025 | 7.665 |
| 01:06 ET | 8133 | 7.65 |
| 01:08 ET | 12952 | 7.65 |
| 01:10 ET | 9945 | 7.665 |
| 01:12 ET | 5806 | 7.675 |
| 01:14 ET | 11270 | 7.66 |
| 01:15 ET | 7324 | 7.655 |
| 01:17 ET | 18251 | 7.71 |
| 01:19 ET | 5980 | 7.7101 |
| 01:21 ET | 4709 | 7.705 |
| 01:24 ET | 5678 | 7.715 |
| 01:26 ET | 3768 | 7.71 |
| 01:28 ET | 4131 | 7.725 |
| 01:30 ET | 3315 | 7.715 |
| 01:32 ET | 9284 | 7.71 |
| 01:33 ET | 18200 | 7.7201 |
| 01:35 ET | 8374 | 7.739 |
| 01:37 ET | 15485 | 7.74 |
| 01:39 ET | 3002 | 7.756 |
| 01:42 ET | 4126 | 7.755 |
| 01:44 ET | 2360 | 7.77 |
| 01:46 ET | 1395 | 7.755 |
| 01:48 ET | 2215 | 7.755 |
| 01:50 ET | 2919 | 7.76 |
| 01:51 ET | 8004 | 7.745 |
| 01:53 ET | 5796 | 7.755 |
| 01:55 ET | 12667 | 7.725 |
| 01:57 ET | 9359 | 7.755 |
| 02:00 ET | 4522 | 7.745 |
| 02:02 ET | 5397 | 7.735 |
| 02:04 ET | 7137 | 7.725 |
| 02:06 ET | 6582 | 7.71 |
| 02:08 ET | 5372 | 7.7299 |
| 02:09 ET | 4506 | 7.72 |
| 02:11 ET | 3131 | 7.725 |
| 02:13 ET | 5526 | 7.73 |
| 02:15 ET | 50222 | 7.705 |
| 02:18 ET | 10928 | 7.69 |
| 02:20 ET | 8457 | 7.725 |
| 02:22 ET | 4050 | 7.715 |
| 02:24 ET | 5456 | 7.71 |
| 02:26 ET | 8753 | 7.7 |
| 02:27 ET | 120334 | 7.67 |
| 02:29 ET | 10837 | 7.63 |
| 02:31 ET | 20403 | 7.6 |
| 02:33 ET | 18369 | 7.61 |
| 02:36 ET | 23032 | 7.585 |
| 02:38 ET | 17869 | 7.62 |
| 02:40 ET | 20824 | 7.55 |
| 02:42 ET | 19901 | 7.575 |
| 02:44 ET | 14144 | 7.555 |
| 02:45 ET | 22161 | 7.5587 |
| 02:47 ET | 18038 | 7.515 |
| 02:49 ET | 12328 | 7.52 |
| 02:51 ET | 87776 | 7.555 |
| 02:54 ET | 12865 | 7.55 |
| 02:56 ET | 19191 | 7.555 |
| 02:58 ET | 18571 | 7.525 |
| 03:00 ET | 106207 | 7.495 |
| 03:02 ET | 41015 | 7.44 |
| 03:03 ET | 31278 | 7.485 |
| 03:05 ET | 23111 | 7.445 |
| 03:07 ET | 16005 | 7.43 |
| 03:09 ET | 31116 | 7.455 |
| 03:12 ET | 20572 | 7.43 |
| 03:14 ET | 16994 | 7.425 |
| 03:16 ET | 16820 | 7.42 |
| 03:18 ET | 30650 | 7.42 |
| 03:20 ET | 48300 | 7.4 |
| 03:21 ET | 36145 | 7.42 |
| 03:23 ET | 22567 | 7.44 |
| 03:25 ET | 27043 | 7.425 |
| 03:27 ET | 23495 | 7.445 |
| 03:30 ET | 23908 | 7.44 |
| 03:32 ET | 58334 | 7.49 |
| 03:34 ET | 35054 | 7.47 |
| 03:36 ET | 103078 | 7.51 |
| 03:38 ET | 35295 | 7.52 |
| 03:39 ET | 51772 | 7.505 |
| 03:41 ET | 157581 | 7.48 |
| 03:43 ET | 51890 | 7.47 |
| 03:45 ET | 37742 | 7.46 |
| 03:48 ET | 37468 | 7.46 |
| 03:50 ET | 38866 | 7.45 |
| 03:52 ET | 79479 | 7.44 |
| 03:54 ET | 52065 | 7.44 |
| 03:56 ET | 166464 | 7.4 |
| 03:57 ET | 106036 | 7.415 |
| 03:59 ET | 326318 | 7.42 |
Jul 29, 2024
Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024, from 4:01PM ET on Monday Jul 29, 2024 by Dow Jones
4:01PM ET on Monday Jul 29, 2024 by Dow JonesDJ Iovance Biotherapeutics Cut to Neutral From Overweight by Piper Sandler, from 5:47AM ET on Monday Jul 29, 2024 by Dow Jones
5:47AM ET on Monday Jul 29, 2024 by Dow Jones
Jul 19, 2024
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4), from 5:00PM ET on Friday Jul 19, 2024 by Dow Jones
5:00PM ET on Friday Jul 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Iovance Biotherapeutics Inc | 2.3B | -4.1x | --- |
CG Oncology Inc | 2.3B | -27.5x | --- |
Janux Therapeutics Inc | 2.1B | -30.4x | --- |
Structure Therapeutics Inc | 2.1B | -15.5x | --- |
Celldex Therapeutics Inc | 2.5B | -11.5x | --- |
Vera Therapeutics Inc | 2.1B | -17.6x | --- |
Company Information
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, Amtagvi (lifileucel), is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. The Company also marketing Proleukin (aldesleukin), aninterleukin-2, or IL-2, product used in the Amtagvi treatment regimen. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings for solid tumor cancers. Amtagvi and Proleukin are part of a treatment regimen that also includes lymphodepletion. The Company is also developing next generation therapies using TIL, such as genetically modified TIL cell therapy.
Contact Information
- Headquarters
- 825 INDUSTRIAL ROAD, 4TH FLOORSAN CARLOS, CA, United States 94070
- Phone
- 650-260-7120
- Fax
- 302-697-4597
Executives
- Independent Chairman of the Board
- Iain Dukes
- Interim President, Interim Chief Executive Officer, General Counsel, Corporate Secretary
- Frederick Vogt
- Chief Financial Officer
- Jean-Marc Bellemin
- Chief Operating Officer
- Igor Bilinsky
- Chief Medical Officer
- Friedrich Graf Finckenstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
|---|---|
Revenue (TTM) | $1.9M |
Shares Outstanding | 279.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.65 |
EPS | $-1.82 |
Book Value | $2.28 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 1,090.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -24,549.63% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
